| Abbreviations | Meaning |
 | MPL | Maximum Permissible Level; Melphalan; Mesiopulpolingual; Myeloproliferative Leukemia |
| TNFR1 | Tumor Necrosis Factor Type 1 Receptor |
| IPA | Infiltrating Pancreatic Ductal Adenocarcinoma |
| MAGE | Melanoma Antigen |
| BTSG | Brain Tumor Study Group |
| FACT-B | Functional Assessment Of Cancer Therapy-breast |
| CALLA | Common Acute Lymphoblastic Leukemia Antigen |
| DNT | Dermonecrotic Toxin; Did Not Test; 2,4-dinitrotoluene; Dysembryoplastic Neuroepithelial Tumor |
| TLS | Thoracolumbosacral; Total Least Squares; Tourette-like Syndrome; Translaminar Screw; Tumor Lysis Syndrome |
| HD | Hodgkin's Disease (lymphoma) |
| LMM | Lactobacillus Maintenance Medium; Laser Microbeam Microdissection; Lentigo Maligna Melanoma; Light Meromyosin |
| HBC | Hereditary Breast Cancer |
| DIN | Damage Inducible [gene]; Digital Imaging Network; Ductal Intraepithelial Neoplasia |
| LNDS | Lymph Node [cancer] Negative Dataset |
| NCIC | National Cancer Institute Of Canada |
Browse by Letter:
